CROSS-TALK BETWEEN NEUROMELANIN AND SYNUCLEIN IN PARKINSON’S DISEASE

• Marta García-Gómara,
• Ana Garcia-Osta,
• Mar Cuadrado-Tejedor

Affiliations

Marta García-Gómara

CIMA - University of Navarra, Gene Therapy For Neurological Diseases, Pamplona, Spain; University of Navarra, Department Of Pathology, Anatomy And Physiology, School Of Medicine, Pamplona, Spain; Navarra Institute for Health Research, Idisna, Pamplona, Spain

Ana Garcia-Osta

CIMA - University of Navarra, Gene Therapy For Neurological Diseases, Pamplona, Spain; Navarra Institute for Health Research, Idisna, Pamplona, Spain

Mar Cuadrado-Tejedor

CIMA - University of Navarra, Gene Therapy For Neurological Diseases, Pamplona, Spain; University of Navarra, Department Of Pathology, Anatomy And Physiology, School Of Medicine, Pamplona, Spain; Navarra Institute for Health Research, Idisna, Pamplona, Spain